Vanguard Group Inc Ampio Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.08 - $21.0 $132,970 - $34.9 Million	1,662,127 Added 20.05%	9,954,092 $602,000
Q2 2022 Aug 12, 2022	SELL	$0.16 - $0.47 $162,459 - $477,225	-1,015,373 Reduced 10.91%	8,291,965 $1.39 Million
Q1 2022 May 13, 2022	BUY	$0.42 - $0.62 $32,685 - $48,249	77,822 Added 0.84%	9,307,338 $4.38 Million
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $11,732 - $35,826	-20,951 Reduced 0.23%	9,229,516 $5.26 Million
Q3 2021 Nov 12, 2021	BUY	$1.21 - $1.8 $77,875 - $115,848	64,360 Added 0.7%	9,250,467 $15.4 Million
Q2 2021 Aug 13, 2021	BUY	$1.56 - $1.98 $14.3 Million - $18.2 Million	9,186,107 New	9,186,107 $15.3 Million

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.